Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Public ClinicalTrials.gov record NCT05587712. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care
Study identification
- NCT ID
- NCT05587712
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Sotatercept Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2023
- Primary completion
- Sep 20, 2028
- Completion
- Sep 20, 2028
- Last update posted
- Apr 19, 2026
2023 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606) | Los Angeles | California | 90095 | Recruiting |
| Stanford University School of Medicine ( Site 1603) | Palo Alto | California | 94304 | Recruiting |
| UCSF Benioff Children's Hospital San Francisco ( Site 1611) | San Francisco | California | 94158 | Recruiting |
| Children's Hospital Colorado ( Site 1609) | Aurora | Colorado | 80045 | Recruiting |
| Children's National Medical Center ( Site 1600) | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Cincinnati Children's Hospital Medical Center ( Site 1602) | Cincinnati | Ohio | 45229 | Recruiting |
| Children's Hospital of Philadelphia (CHOP) ( Site 1608) | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Monroe Carell Jr. Children's Hospital ( Site 1601) | Nashville | Tennessee | 37232 | Completed |
| Seattle Children's Hospital ( Site 1605) | Seattle | Washington | 98105 | Recruiting |
| Children's Wisconsin ( Site 1610) | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05587712, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05587712 live on ClinicalTrials.gov.